These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 12364858)

  • 1. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
    Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
    Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-transplant presence of antibodies to MICA and HLA class I or II are associated with an earlier onset of bronchiolitis obliterans syndrome in lung transplant recipients.
    Lyu DM; Grazia TJ; Benson AB; Cagle LR; Freed BM; Zamora MR
    Clin Transpl; 2012; ():237-46. PubMed ID: 23721028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation.
    Safavi S; Robinson DR; Soresi S; Carby M; Smith JD
    J Heart Lung Transplant; 2014 Dec; 33(12):1273-81. PubMed ID: 25130554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological link between primary graft dysfunction and chronic lung allograft rejection.
    Bharat A; Kuo E; Steward N; Aloush A; Hachem R; Trulock EP; Patterson GA; Meyers BF; Mohanakumar T
    Ann Thorac Surg; 2008 Jul; 86(1):189-95; discussion 196-7. PubMed ID: 18573422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation.
    Jaramillo A; Smith MA; Phelan D; Sundaresan S; Trulock EP; Lynch JP; Cooper JD; Patterson GA; Mohanakumar T
    Transplantation; 1999 Apr; 67(8):1155-61. PubMed ID: 10232567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
    Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
    Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation.
    Morrell MR; Pilewski JM; Gries CJ; Pipeling MR; Crespo MM; Ensor CR; Yousem SA; D'Cunha J; Shigemura N; Bermudez CA; McDyer JF; Zeevi A
    J Heart Lung Transplant; 2014 Dec; 33(12):1288-94. PubMed ID: 25443870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant allorecognition of mismatched donor HLA class I- and class II-derived peptides in pediatric lung transplant recipients with bronchiolitis obliterans syndrome.
    Lu KC; Jaramillo A; Mendeloff EN; Huddleston CB; Sweet SC; Patterson GA; Mohanakumar T
    J Heart Lung Transplant; 2003 Jan; 22(1):35-43. PubMed ID: 12531411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection.
    Bharat A; Narayanan K; Street T; Fields RC; Steward N; Aloush A; Meyers B; Schuessler R; Trulock EP; Patterson GA; Mohanakumar T
    Transplantation; 2007 Jan; 83(2):150-8. PubMed ID: 17264811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection.
    Bharat A; Saini D; Steward N; Hachem R; Trulock EP; Patterson GA; Meyers BF; Mohanakumar T
    Ann Thorac Surg; 2010 Oct; 90(4):1094-101. PubMed ID: 20868794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Donor-Recipient Human Leukocyte Antigen Matching on Bronchiolitis Obliterans-Free Survival Among Lung Transplant Recipients With Connective Tissue Diseases.
    Courtwright AM; Diamond JM; Sandorfi N; Goldberg HJ
    Clin Transplant; 2024 Aug; 38(8):e15426. PubMed ID: 39136242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome.
    Sundaresan S; Mohanakumar T; Smith MA; Trulock EP; Lynch J; Phelan D; Cooper JD; Patterson GA
    Transplantation; 1998 Mar; 65(5):648-53. PubMed ID: 9521198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients.
    Snyder LD; Wang Z; Chen DF; Reinsmoen NL; Finlen-Copeland CA; Davis WA; Zaas DW; Palmer SM
    Chest; 2013 Jul; 144(1):226-233. PubMed ID: 23328795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.
    Chalermskulrat W; Neuringer IP; Schmitz JL; Catellier DJ; Gurka MJ; Randell SH; Aris RM
    Chest; 2003 Jun; 123(6):1825-31. PubMed ID: 12796156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome.
    SivaSai KS; Smith MA; Poindexter NJ; Sundaresan SR; Trulock EP; Lynch JP; Cooper JD; Patterson GA; Mohanakumar T
    Transplantation; 1999 Apr; 67(8):1094-8. PubMed ID: 10232557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchiolitis obliterans syndrome due to donor-specific HLA-antibodies.
    Kauke T; Kneidinger N; Martin B; Dick A; Schneider C; Schramm R; Meimarakis G; Preissler G; Eickelberg O; von Dossow V; Behr J; Hatz R; Neurohr C; Winter H
    Tissue Antigens; 2015 Sep; 86(3):178-85. PubMed ID: 26204790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antibodies to lung self-antigens (Kα1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: Single center experience.
    Rao U; Sharma M; Mohanakumar T; Ahn C; Gao A; Kaza V
    Transpl Immunol; 2019 Jun; 54():65-72. PubMed ID: 30794945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Presence of Pretransplant HLA Antibodies Does Not Impact the Development of Chronic Lung Allograft Dysfunction or CLAD-Related Death.
    Zazueta OE; Preston SE; Moniodis A; Fried S; Kim M; Townsend K; Wood I; Boukedes S; Guleria I; Camp P; El-Chemaly S; Rosas IO; Chandraker A; Milford E; Goldberg HJ
    Transplantation; 2017 Sep; 101(9):2207-2212. PubMed ID: 27893614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.